Bioinformatics analysis of purified and identified novel bacteriocin‐like inhibitory substances produced by Streptomyces sp.
- 25 February 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Food Science and Technology
- Vol. 59 (4) , 2647-2658
Abstract
Summary: Bacteriocins are antimicrobial peptides synthesised ribosomally by bacteria that can be used as natural preservatives. One potential bacteriocin‐producing bacteria that has yet to be widely studied is Streptomyces sp. Bioinformatics analysis has been conducted on the purified and identified bacteriocin‐like inhibitory substances (BLIS) produced by Streptomyces sp. The BLIS fraction, purified by reversed‐phase high‐performance liquid chromatography, showed significantly increased specific activities against E. coli, L. monocytogenes, S. aureus and S. typhimurium (1.2–189.4 folds). Identification of four purified BLIS fractions using HR‐LC‐ESI‐MS/MS revealed molecular mass from 1287.51 to 1812.85 Da with the sequences of TAEAEAAEGAEEAAP (fraction AS531), TQGGINANKTGSQGYG (fraction AS822), SGGYGGMGAGGIGGQRSGPQ (fraction AS857) and PGGAKGGFGGGGRPGGQGMPGG (fraction AS1121). These peptide sequences have a minimum of 2 hydrophobic amino acids, a net charge of −4 to +2, an isoelectric point of 2.68–11.71 and a hydrophobicity of 20.44–27.46 kcal mol−1. The results of molecular docking analysis between purified BLIS and the penicillin‐binding protein 3 (PBP‐3) receptor by methicillin‐resistant Staphylococcus aureus (MRSA) also showed that four fractions had low binding energy (−7.5 to −8.1 kcal mol−1) with 17–25 hydrogen bonds and distances in vitro characterisation revealed that the four purified‐BLIS have a low to moderate LC50 (68.81–200.35 μgmL−1) against A. salina and the ability to maintain 50% antibacterial activity against E. coli up to 100 °C for 30 min and in the pH range of 2.0–8.0, especially fractions AS531 and AS822. Based on the antibacterial spectrum, physicochemical characteristics and peptide sequence, BLIS produced by Streptomyces sp., is a novel bacteriocin with promising applications as a food preservative.Keywords
Funding Information
- Kementerian Riset, Teknologi dan Pendidikan Tinggi (2680/IT3.L1/PN/2020)
This publication has 55 references indexed in Scilit:
- New bacteriocin-like substances produced by Streptomyces species with activity against pathogensFolia Microbiologica, 2020
- Purification of a Bacteriocin‐Like Inhibitory Substance Derived from Pediococcus acidilactici Kp10 by an Aqueous Micellar Two‐Phase SystemBiotechnology Progress, 2018
- Evaluation of the antimicrobial activity of bacteriocin-like inhibitory substances of enological importance produced by Oenococcus oeni isolated from wineEuropean Food Research and Technology, 2018
- In-silico design and molecular docking evaluation of peptides derivatives from bacteriocins and porcine beta defensin-2 as inhibitors of Hepatitis E virus capsid proteinVirusDisease, 2017
- Purification and characterization of bacteriocin F1, a novel bacteriocin produced by Lactobacillus paracasei subsp. tolerans FX-6 from Tibetan kefir, a traditional fermented milk from Tibet, ChinaFood Control, 2014
- Role of helicity of α-helical antimicrobial peptides to improve specificityProtein & Cell, 2014
- Alpha-helical cationic antimicrobial peptides: relationships of structure and functionProtein & Cell, 2010
- Binding, inactivation, and adhesion forces between antimicrobial peptide cecropin P1 and pathogenic E. coliColloids and Surfaces B: Biointerfaces, 2010
- Inhibition of Fungi and Gram-Negative Bacteria by Bacteriocin BacTN635 Produced by Lactobacillus plantarum sp. TN635Applied Biochemistry and Biotechnology, 2009
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009